Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer
收藏数据链接:
官方服务:
资源简介:
Source data for the manuscript entitled 'Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer '.
题为《抗表皮生长因子受体(EGFR)抗体JMT101联合奥希替尼治疗EGFR外显子20插入阳性非小细胞肺癌的1b期临床试验》的研究手稿的源数据
创建时间:
2023-06-13



